Bayer’s consumer health business benefits from a narrow economic moat, largely because of its strong brand power. Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter ...

How a chemical and pharmaceutical giant with an appalling record of corporate crimes became a key player in the development, commercialization and sale of GM crops ...

Dr Mohamed Galal, Vice President of Bayer and Executive Director for the Middle East and Pakistan, announced that the company ...

Ahram's Pharmaceutical Conference, which began Saturday under the patronage of Prime Minister Mostafa Madbouly, discussed the ...

But the Centers for Medicare and Medicaid Services has decided to withhold information identifying ... finds that regular use of low-dose aspirin by women under 65 years of age does not prevent ...

Taking aspirin regularly cuts the risk of developing pancreatic cancer by 40% in people with diabetes and by 20% in the ...

Regular use of aspirin may cut the risk of pancreatic cancer in people with diabetes by 40%, a study has found. It may also ...

A study suggests that a common household medicine - aspirin - may provide some much-needed relief for those with heat sensitivity.

Data from the phase I exPDite study at 24 months continue to show a favorable safety profile in all 12 participants in the trial’s high and low-dose cohorts. Year to date, shares of Bayer have ...

Aspirin is not only one of the best-documented medicines in the world, but also one of the most frequently used drugs of all times. In addition to its role as an analgesic, aspirin is being ...

If you're wondering why there hasn't been much news about it, just remember aspirin is dirt cheap (costing just a couple of pennies per 75mg tablet), so there's no incentive for drug companies to ...